ACTIVITY IN 2011
(Unaudited data)
- CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2011
| thousands of euros | 2010 | 2011 | Variation at current exchange rates |
Variation at constant exchange rates |
| France | 279,052 | 292,181 | +4.7% | +4.7% |
| International : | 241,334 | 231,034 | -4.3% | -3.5% |
| Incl. Europe excluding France | 193,102 | 185,014 | -4.2% | -4.0% |
| Incl. North America | 41,819 | 38,416 | -8.1% | -4.8% |
| Incl. Other countries | 6,413 | 7,604 | +18.6% | +18.5% |
| Group Total | 520,386 | 523,215 | +0.5% | +0.9% |
| thousands of euros | 2010 | 2011 | Variation at current exchange rates |
Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 267,460 | 265,636 | -0.7% | -0.5% |
| OTC Specialties | 251,985 | 257,748 | +2.3% | +2.9% |
| Other | 0,941 | -0,169 | -118.0% | -121.2% |
| Group Total | 520,386 | 523,215 | +0.5% | +0.9% |
- QUARTERLY ACTIVITY IN 2011 (variation at current rate)
| 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter | |||||||||
| thousands of euros | 2010 | 2011 | Var. | 2010 | 2011 | Var. | 2010 | 2011 | Var. | 2010 | 2011 | Var. |
| France | 66,313 | 70,466 | +6.3% | 60,043 | 59,744 | -0.5% | 75,679 | 79,943 | +5.6% | 77,017 | 82,028 | +6.5% |
| International : | 55,047 | 58,478 | +6.2% | 40,129 | 37,128 | -7.5% | 71,139 | 67,885 | -4.6% | 75,019 | 67,543 | -10.0% |
| Incl. Europe excluding France | 44,854 | 47,024 | +4.8% | 31,223 | 28,880 | -7.5% | 58,806 | 55,013 | -6.5% | 58,219 | 54,097 | -7.1% |
| Incl. North America | 7,976 | 9,566 | +19.9% | 7,732 | 6,113 | -20.9% | 10,988 | 11,077 | +0.8% | 15,123 | 11,660 | -22.9% |
| Incl. Other countries | 2,217 | 1,888 | -14.8% | 1,174 | 2,135 | +81.9% | 1,345 | 1,795 | +33.5% | 1,677 | 1,786 | +6.5% |
| Group Total | 121,360 | 128,944 | +6.3% | 100,172 | 96,872 | -3.3% | 146,818 | 147,828 | +0.7% | 152,036 | 149,571 | -1.6% |
| 1st Quarter | 2nd Quarter | 3rd Quarter | 4th Quarter | |||||||||
| thousands of euros | 2010 | 2011 | Var. | 2010 | 2011 | Var. | 2010 | 2011 | Var. | 2010 | 2011 | Var. |
| Non-proprietary Homeopathic Medicines | 67,467 | 69,371 | +2.8% | 64,246 | 62,414 | -2.9% | 64,979 | 63,246 | -2.7% | 70,768 | 70,605 | -0.2% |
| OTC Specialties | 53,683 | 59,417 | +10.7% | 35,744 | 34,499 | -3.5% | 81,711 | 84,645 | +3.6% | 80,847 | 79,187 | -2.1% |
| Other | 0,210 | 0,156 | -25.7% | 0,182 | -0,041 | -122.5% | 0,128 | -0,063 | -149.2% | 0,421 | -0,221 | -152.5% |
| Group Total | 121,360 | 128,944 | +6.3% | 100,172 | 96,872 | -3.3% | 146,818 | 147,828 | +0.7% | 152,036 | 149,571 | -1.6% |
FOURTH QUARTER HIGHLIGHTS
- On December 2, 2011, the French Supreme Court of Final Appeal definitively ended litigation related to the legality of the Additional Tax on Direct Sales opposing Boiron against the French Social Security Agency (URSSAF). The amount received by BOIRON in 2010 of €12,956 thousand has thereby been finalized as permanently acquired.
- On December 29, 2011, a ministerial ordinance which modified the schedule of “authorized margins for pharmaceutical wholesalers” was published in the Official Journal, effective as of January 1, 2012. The new schedule permits price increases on several reimbursable medicines for the first time in 23 years.
- Business activity in the fourth quarter decreased as compared to the fourth quarter of 2010:
- Sales revenue in France increased by 6.5% thanks to the main specialties.
- Sales decreased primarily in the USA, Poland and Russia.
The decision related to the Additional Tax on Direct Sales and favourable fourth quarter performance in France limited the decrease in full year profitability announced on October 20, 2011.
Next update: March 14th 2012, after the close of the stock market, publication of 2011 results.
Financial information manager: Philippe MONTANT
Contact for FINANCIAL information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boiron.com
